BAY88-8223
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BAY88-8223, covering 2016-10-17 to 2023-11-02. Get the full timeline:
Most recent: Clinical Trial Update: BAY88-8223, Dose Finding Study in Patients With HRPC [Phase 2]